CG100 Alcohol-use disorders - diagnosis and clinical management of alcohol-related physical complications: surveillance review proposal
A review has been undertaken to decide whether NICE should update this guideline.
Registered stakeholders for the guideline are invited to comment on the provisional review decision via this website.
Individuals and organisations not registered as stakeholders are not able to comment, we recommend that you register as a stakeholder or you contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.
Note that the provisional review decision presented here does not constitute the Institute's formal decision on this topic. The decision is provisional and may change after consultation.
Consultation dates: 9am on 6 March to 5pm on 20 March 2015
Consultation document:
How to submit your comments:
Please provide all responses to the review proposal documents using the comments proforma (ensuring all relevant fields are completed, including your organisation’s full name) and forward this electronically by 5pm on 06/03/15 at the very latest to this email address:
alcoholusedisorders.surveillance@nice.org.uk
The Institute is unable to accept:
- Comments from non-registered organisations – if you wish your comments to be considered please register via the NICE website
- Comments from individuals – please contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them.
- Comments received after the consultation deadline (5pm)
- Comments that are not on the correct proforma
- More than one response per stakeholder organisation
- Confidential information or other material that you would not wish to be made public
- Personal medical information about yourself or another person from which your or the person’s identity could be ascertained.
What will happen to your comments:
- Comments from registered stakeholders and nominated expert reviewers ONLY will be sent to the review team at the end of the consultation. These will inform the final decision made by the NICE Guidance Executive.
- No action will be taken upon receipt of personal, individual comments, comments from non-registered organisations and late comments.
Anticipated review decision date: April 2015
Further information
More information on NICE’s guideline review process
This page was last updated: 09 March 2015
-
-
-
-
CG100 Alcohol-use disorders - physical complications: evidence update (PDF 315 KB)
-
Alcohol use disorders - clinical management: scope consultation comments (PDF 132 KB)
-
Alcohol use disorders - clinical management: final scope (PDF 45 KB)
-
-
Alcohol use disorders: minutes of GDG meeting 8 - 10 March 2009 (PDF 43 KB)
-
Alcohol use disorders: minutes of GDG meeting 9 - 21 April 2009 (PDF 45 KB)
-
Alcohol use disorders: minutes of GDG meeting 10 - 19 May 2009 (PDF 46 KB)
-
Alcohol use disorders: minutes of GDG meeting 11 - 16 June 2009 (PDF 47 KB)
-
Alcohol use disorders - clinical management: full guideline for consultation (PDF 1.82 MB)
-
Corticosteroid treatment for alcohol-related hepatitis (PDF 152 KB)
-
-
-
-
Indications for admission to hospital care - health economics (PDF 95 KB)
-
-
-
Nutritional support for acute alcohol-related pancreatitis (PDF 153 KB)
-
Nutritional support in alcohol-related liver disease (PDF 52 KB)
-
-
Prophylactic antibiotic treatment in acute pancreatitis (PDF 77 KB)
-
-
-
-
-
-
-
-
Alcohol use disorders - clinical management: NICE version for consultation (PDF 103 KB)
-
Alcohol use disorders - clinical management: consultation comments proforma (MSWord 50 KB)
-
Alcohol use disorders - clinical management: list of stakeholders (PDF 33 KB)
-
Alcohol use disorders - clinical management: pre publication check error table (PDF 26 KB)
-
Alcohol use disorders - clinical management: full guidelines (PDF 2.72 MB)
-
Alcohol use disorders - clinical management: consultation comments table (PDF 890 KB)